[Glucocorticoid and Bone. Osteocytic osteolysis

potential modulation by glucocorticoids]

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Glucocorticoid-induced osteoporosis is mediated primarily by activity of glucocorticoid receptors expressed in osteoblasts, osteocytes and osteoclasts. Bone matrix harbors numerous osteocyte lacunae containing osteocytes. Each osteocyte extends numerous dendrites into canaliculi where dendrite tips make contact with dendrites of nearby neighboring osteocytes and form gap junctions between osteocytes. Osteocytes near the bone surface also contact osteoblasts and osteoclasts through dendrites, thereby establishing communication within an entire bone. Curiously, osteocytes themselves have been shown to dissolve bone matrix under several conditions in a process known as osteocytic osteolysis. The estimated surface area of osteocyte lacunae and canaliculi is huge, and the lacuno-canalicular network is well connected to the blood circulation, suggesting that osteocytic osteolysis may function in pathogenesis and treatment of osteoporosis. Glucocorticoids decrease bone formation by osteoblasts and induce apoptosis in osteocytes. Moreover, glucocorticoids reportedly increase the size of osteocyte lacunae, and enhance perilacunar remodeling. In this review, we discuss whether and how osteocytic osteolysis contributes to glucocorticoid-induced osteoporosis using mouse models.

Original languageEnglish
Pages (from-to)1337-1342
Number of pages6
JournalClinical calcium
Volume24
Issue number9
DOIs
Publication statusPublished - 2014 Sep 1

Fingerprint

Osteocytes
Osteolysis
Glucocorticoids
Bone and Bones
Dendrites
Osteoblasts
Osteoporosis
Bone Matrix
Osteoclasts
Blood Circulation
Gap Junctions
Glucocorticoid Receptors
Osteogenesis
Communication

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Glucocorticoid and Bone. Osteocytic osteolysis : potential modulation by glucocorticoids]. / Matsuo, Koichi.

In: Clinical calcium, Vol. 24, No. 9, 01.09.2014, p. 1337-1342.

Research output: Contribution to journalArticle

@article{f4e03949e0cd4c22a5df175c5cd05714,
title = "[Glucocorticoid and Bone. Osteocytic osteolysis: potential modulation by glucocorticoids]",
abstract = "Glucocorticoid-induced osteoporosis is mediated primarily by activity of glucocorticoid receptors expressed in osteoblasts, osteocytes and osteoclasts. Bone matrix harbors numerous osteocyte lacunae containing osteocytes. Each osteocyte extends numerous dendrites into canaliculi where dendrite tips make contact with dendrites of nearby neighboring osteocytes and form gap junctions between osteocytes. Osteocytes near the bone surface also contact osteoblasts and osteoclasts through dendrites, thereby establishing communication within an entire bone. Curiously, osteocytes themselves have been shown to dissolve bone matrix under several conditions in a process known as osteocytic osteolysis. The estimated surface area of osteocyte lacunae and canaliculi is huge, and the lacuno-canalicular network is well connected to the blood circulation, suggesting that osteocytic osteolysis may function in pathogenesis and treatment of osteoporosis. Glucocorticoids decrease bone formation by osteoblasts and induce apoptosis in osteocytes. Moreover, glucocorticoids reportedly increase the size of osteocyte lacunae, and enhance perilacunar remodeling. In this review, we discuss whether and how osteocytic osteolysis contributes to glucocorticoid-induced osteoporosis using mouse models.",
author = "Koichi Matsuo",
year = "2014",
month = "9",
day = "1",
doi = "CliCa140913371342",
language = "English",
volume = "24",
pages = "1337--1342",
journal = "Clinical calcium",
issn = "0917-5857",
publisher = "Iyaku (Medicine & Drug) Journal Co",
number = "9",

}

TY - JOUR

T1 - [Glucocorticoid and Bone. Osteocytic osteolysis

T2 - potential modulation by glucocorticoids]

AU - Matsuo, Koichi

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Glucocorticoid-induced osteoporosis is mediated primarily by activity of glucocorticoid receptors expressed in osteoblasts, osteocytes and osteoclasts. Bone matrix harbors numerous osteocyte lacunae containing osteocytes. Each osteocyte extends numerous dendrites into canaliculi where dendrite tips make contact with dendrites of nearby neighboring osteocytes and form gap junctions between osteocytes. Osteocytes near the bone surface also contact osteoblasts and osteoclasts through dendrites, thereby establishing communication within an entire bone. Curiously, osteocytes themselves have been shown to dissolve bone matrix under several conditions in a process known as osteocytic osteolysis. The estimated surface area of osteocyte lacunae and canaliculi is huge, and the lacuno-canalicular network is well connected to the blood circulation, suggesting that osteocytic osteolysis may function in pathogenesis and treatment of osteoporosis. Glucocorticoids decrease bone formation by osteoblasts and induce apoptosis in osteocytes. Moreover, glucocorticoids reportedly increase the size of osteocyte lacunae, and enhance perilacunar remodeling. In this review, we discuss whether and how osteocytic osteolysis contributes to glucocorticoid-induced osteoporosis using mouse models.

AB - Glucocorticoid-induced osteoporosis is mediated primarily by activity of glucocorticoid receptors expressed in osteoblasts, osteocytes and osteoclasts. Bone matrix harbors numerous osteocyte lacunae containing osteocytes. Each osteocyte extends numerous dendrites into canaliculi where dendrite tips make contact with dendrites of nearby neighboring osteocytes and form gap junctions between osteocytes. Osteocytes near the bone surface also contact osteoblasts and osteoclasts through dendrites, thereby establishing communication within an entire bone. Curiously, osteocytes themselves have been shown to dissolve bone matrix under several conditions in a process known as osteocytic osteolysis. The estimated surface area of osteocyte lacunae and canaliculi is huge, and the lacuno-canalicular network is well connected to the blood circulation, suggesting that osteocytic osteolysis may function in pathogenesis and treatment of osteoporosis. Glucocorticoids decrease bone formation by osteoblasts and induce apoptosis in osteocytes. Moreover, glucocorticoids reportedly increase the size of osteocyte lacunae, and enhance perilacunar remodeling. In this review, we discuss whether and how osteocytic osteolysis contributes to glucocorticoid-induced osteoporosis using mouse models.

UR - http://www.scopus.com/inward/record.url?scp=84925286379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925286379&partnerID=8YFLogxK

U2 - CliCa140913371342

DO - CliCa140913371342

M3 - Article

VL - 24

SP - 1337

EP - 1342

JO - Clinical calcium

JF - Clinical calcium

SN - 0917-5857

IS - 9

ER -